WO2005110451A1 - コーヒー豆抽出物、抽出方法及び同抽出物を含む組成物 - Google Patents
コーヒー豆抽出物、抽出方法及び同抽出物を含む組成物 Download PDFInfo
- Publication number
- WO2005110451A1 WO2005110451A1 PCT/JP2005/009306 JP2005009306W WO2005110451A1 WO 2005110451 A1 WO2005110451 A1 WO 2005110451A1 JP 2005009306 W JP2005009306 W JP 2005009306W WO 2005110451 A1 WO2005110451 A1 WO 2005110451A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- serine
- extract
- composition
- peptide
- amino acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the present invention relates to a specific extract from coffee beans, a method for producing the extract, a composition comprising the extract, and its use as a medicament and an anti-inflammatory agent.
- This composition is particularly useful as an agent for the treatment and / or prevention of inflammatory conditions.
- the device is connected to a mist fine particle generation tank including means for heating the water storage tank to a predetermined temperature, and means for crushing or atomizing water into a mist, and a mist fine particle generation tank,
- An extraction device that holds a raw material layer for attaching the active ingredients of the raw material to the mist fine particles when the atomized fine particles pass through the raw material layer, and extracts the active ingredient from the raw material layer through the raw material layer
- a condenser connected to the extraction device to liquefy the mist fine particles, a storage tank into which water liquefied by the condenser flows, and a passage between the storage tank and the mist fine particle generation tank,
- a blower for depressurizing the raw material layer in the extraction device, and a condensing device
- a cooling means for cooling the storage tank.
- a process that can easily coagulate the liquid extract produced from the above-mentioned device and the extract produced from Z or the improved condenser and the device having the Z or the improved drying process by drying or freeze-drying Is disclosed in U.S. Pat. No. 6,726,914, the disclosure of which is incorporated herein by reference. From the coagulated or dried extract, pharmaceutical compositions and cosmetics, perfumes and other compositions useful for the production of Z or flavor enhancers can be readily produced. In addition, coagulation of the extract with a non-nutritive absorbent makes analysis of the dry extract easier than analysis of the extract itself.
- the present inventor has found that a combination of compounds can be extracted and isolated from coffee beans, and when combined with a biologically active peptide also extracted from coffee beans, the combination can be used in animals, especially humans. Has been found to have anti-inflammatory activity when administered to mammals containing
- compositions having useful biological activities Accordingly, it is an object of the present invention to provide compositions having useful biological activities.
- the present invention has solved the problems of the prior art.
- the present invention relates to an extract solution containing basically four compounds from coffee beans, a composition containing both a bioactive peptide extracted from coffee beans and these compounds, a composition having anti-inflammatory activity, And a method for producing the extract and the composition.
- the compounds and peptides are preferably obtained using a heating, extraction, and condensation system that efficiently recovers the raw materials.
- the condenser comprises at least two preferably cylindrical vessels, at least one of which has a cooling medium for condensing moisture from the air stream.
- a third container may be added.
- the obtained liquid extract is brought into contact with a desiccant and the material soaked in the extract is dried. Alternatively, soak plant or animal food in the extract and dry.
- the compounds extracted and isolated are genistein, flavonic acid, diadzein and daidzin.
- the peptide is a pentapeptide and has the amino acid sequence SEQ ID NO: 0.1: tyrosine-glycine-serine-arginine-serine (YGSRS).
- YGSRS tyrosine-glycine-serine-arginine-serine
- FIG. 1 is a schematic diagram of one embodiment of an extraction dryer used to extract the active ingredient (s) according to the present invention.
- FIG. 2 is a schematic diagram of another embodiment of an extractor / dryer device used to extract the active ingredient (s) according to the present invention.
- FIG. 3 is a partial perspective view of the outer cylinder of an extraction device used to extract the active ingredient (s) according to the present invention.
- FIG. 4 (a), (b) and (c) are each a perspective view showing the structure of the inner cylinder of the extraction device used for extracting the active ingredient (s) according to the present invention.
- FIG. 5 is a plan view of the air flow regulating means used in the extraction device used to extract the active ingredient (s) according to the present invention.
- FIG. 6 is a sectional view taken along line 6-6 in FIG.
- FIG. 7 is a schematic diagram of one embodiment of a condenser used in an extraction system used to extract active ingredient (s) according to the present invention.
- FIG. 8 is a schematic diagram of a condensing device used in an extraction system used to extract active ingredient (s) according to the present invention.
- FIG. 9 is a cross-sectional view of a condensing section of a condensing device of an extraction system used to extract an active component or components according to another embodiment of the present invention.
- FIG. 10 is a top view of the condensing section of the apparatus of FIG. BEST MODE FOR CARRYING OUT THE INVENTION
- the preferred raw material from which the extract can be made into an extraction system from which the peptide and genistein, flavonic acid, daidzein and daidzin can be isolated is coffee beans.
- FIG. 1 is a schematic view showing the structure of a first embodiment of the manufacturing apparatus.
- 1 is a housing or container having a reservoir for liquid, preferably water, therein.
- Housing 1 is preferably made of stainless steel.
- the size of the housing 1 is not particularly limited, and in the illustrated embodiment, it usually depends on the amount of raw material 4 used and the desired extraction rate of the active ingredient extracted therefrom.
- the housing 1 includes a means H for heating the storage tank, but this means is not particularly limited, and may include an electric heating element or a coil, an ultraviolet heating element or an infrared heating element, a burner, and the like.
- Heating means H is used to heat the liquid in housing 1 sufficiently to the temperature required to evaporate the liquid. It must be capable of heating.
- the heater may be connected to a gauge (not shown) so that the operator can specify a desired liquid temperature, or may be connected to a switch (not shown) for starting the heater.
- the heating means H can be located inside or outside the housing 1.
- a means (not shown) for generating mist-like fine particles of water, that is, mist may be arbitrarily provided.
- Suitable means include an ultrasonic generator with one or more sets of vibrators (depending on the size of the tank), located at the bottom of the housing 1 and each capable of crushing and atomizing water. Is included. Conventional ultrasonic generators used in home ultrasonic humidifiers can also be used. Centrifugal atomization methods can also be used.
- FIG. 3 is a perspective view of the outer appearance of the outer cylinder.
- This is a main element of the extraction device 2 and includes a first outer cylinder 2a and a second outer cylinder 2b, both of which are detachably connected to each other and are preferably made of stainless steel. .
- a temperature sensor (not shown) can be fixed to the bottom side of the second outer cylinder 2b for detecting the temperature during the extraction operation.
- the hinge lock mechanism C1 joins the cylinder 2a to the cylinder 2b, so that raw materials can be easily put in and out of it.
- Figure 3 shows the lock The extraction device 2 is shown in an open and unfolded state.
- FIG. 4 is a schematic view of the inner cylinder housed in the outer cylinder 2 of FIG.
- the inner cylinder 2c shown in Fig. 4 (a) is of an appropriate shape and size to fit into the above-mentioned outer cylinder, and has a mesh for holding the raw material crushed into small particles. It has at the bottom.
- FIG. 4 (b) shows a guide plate 2d for insertion into the inner cylinder 2c.
- a crushed piece S of a raw material such as coffee powder is transferred to the inner cylinder It has a structure that can be classified in 2c.
- the presence of the guide plate 2d allows the steam from the housing 1 to easily and smoothly pass through the crushed pieces S of the raw material as described below. It should be understood by those skilled in the art that other shapes such as a spiral shape may be used for the guide plate 2d.
- Extractor 2 is in fluid communication with condenser 3 via pipe P2.
- a valve V1 is arranged in the pipe P2, and together with the valve V2 in the pipe P3 (described later), the amount of air flowing into the condenser 3 and the degree of pressure reduction in the condenser are adjusted.
- the extract may be air-cooled or water-cooled in a condenser 3 as disclosed in U.S. Pat.Nos. 5,572,923 and 5,170,977, the disclosures of which are incorporated herein by reference. It is cooled by various methods including
- the condenser 3 includes two concentric cylinders,
- the outer cylinder 4 contains a coolant for cooling the contents.
- the inner and outer cylinders are not coextensive, so that condensate generated during the cooling process can be collected in the lower inner part 5a.
- separate means for collecting condensate such as pipes communicating with the inner cylinder 5 at one end and communicating with the auxiliary vessel at the other end
- the length of the inner cylinder 5 can be shorter than that of the outer cylinder 4 so that the coolant accommodated in the outer cylinder 4 surrounds not only the side surface of the inner cylinder 5 but also the bottom thereof. Again, in this latter embodiment, appropriate means will be provided to collect the condensate at another location.
- the coolant 6 contained in the outer cylinder 4 is preferably a liquid such as water.
- the coolant 6 may also be a solid, such as gas or ice, or another material capable of maintaining a low temperature for an extended period of time.
- the cooling material 6 can be circulated in the outer cylinder 4 to enhance cooling, and can be supplied continuously or frequently during operation.
- the inner cylinder 5 contains one or more air flow control means 36, but as shown, two are optimal.
- the air flow controller 36 includes a plurality of inclined plates 37, and a gap “g” is formed between adjacent inclined plates 37.
- the air flow to be restricted can be adjusted by adjusting the inclination of the inclined plate 37.
- Air entering the inner cylinder 5 rotates the air flow regulator 36 around a vertical axis, thereby forcing airflow in the direction of the wall of the cylinder 5 cooled by the coolant 6 in the outer cylinder. Pointed.
- the amount of water extracted from the air flow can be increased by driving the air flow controller 36 with a motor or the like. The condensate obtained is drained from drain 7 and collected.
- FIG. 7 shows another embodiment of the condenser 3.
- the air flow rate is adjusted using a triple vessel design.
- the outer vessel 4 "contains coolant in its annular portion.
- the intermediate vessel M receives the airflow from the extraction device via a suitable pipe 94, The flow goes out of the device via pipe 93 (and optionally recirculates back to housing 1).
- the central vessel 5 "assists in directing the contents of intermediate vessel M to outer vessel 4"
- the shape of the container is preferably cylindrical, but is not necessarily required.
- the air in the intermediate container M is forcibly forced out of the outer container 4 ".
- Other shapes are also suitable as long as they can enhance cooling against the wall.
- the surface area of the cooling wall is also important.
- FIG. 8 shows still another embodiment of the condensing device. This embodiment is similar to that shown in Fig. 7, except that the central vessel 5 "is filled with a cooling fluid. This cooling fluid may be the same as the cooling fluid contained in the outer vessel 4". It may be different. If the fluids are the same, a connecting means 95 can be provided between the central vessel 5 "and the outer vessel 4" to circulate the cooling fluid therebetween. As in the embodiment of FIG. 7, the central vessel 5 "is preferably, but not necessarily, cylindrical. The surface area of the cooling surface is increased and the medium to be cooled is forcibly applied to the cooling surface.
- Alternative shapes can be used to increase cooling by assisting in cooling. Shortening the central container 5 "also ensures that the medium to be cooled is also exposed to the bottom of the container. I can do it.
- the inlet and outlet of the medium to be cooled can be arranged so that the medium to be cooled moves around the central vessel 5 "before exiting the condenser. As shown in FIG. The 5 "may also be longer than the outer vessel 4" and the intermediate vessel M and include an inlet 96 for introducing cooling fluid therein.
- the condenser can be combined with a heater to increase the temperature of the medium from which the moisture is removed. Condensing can be enhanced by placing multiple devices in series, but the series can be either vertical or horizontal depending on the space available. This device is easier and faster to manufacture than the embodiment of FIG. 2 which uses a rotating device to regulate air flow.
- the condenser 3 has a housing, but the housing may also be made of plastic and, as shown, preferably has one or more spaced-apart cooling surfaces 4a-4n in the form of vanes.
- the cooling surfaces 4a-4n can be made of any heat conducting material, but are preferably metal, most preferably aluminum.
- the cooling surfaces 4a-4n preferably provide a large surface area within the housing for contact with the incoming material and extend through most of the housing 3, as described in more detail below.
- the number of cooling surfaces 4a-4n with a gap between them is not important and depends on the size of the housing of the condenser 3 and on the desired optimum condensation rate. As shown, the cooling surfaces 4a-4n preferably taper toward their free ends.
- the cooling surfaces 4a-4n include equally sized dividers 5 and the condenser housing is divided into two separate compartments or zones, one for the flow of incoming material. The other is for the recirculation of the material flowing out without being condensed in the condenser 3. More specifically, the incoming material from pipe P2 flows downward (based on the orientation of the device shown in FIG. 2) into the first compartment, where the cooling surface 4a-4 located therein Contact with n. Any material that is not condensed at this time has the two compartments communicating across this first compartment. Into the second compartment in the condensing chamber 30 and then upwardly (again with respect to the direction of the apparatus shown in FIG. 2) through the second compartment, where the cooling surface 4a located therein -Touch 4 n. Any material not condensed in the second compartment flows out of the pipe P3 and is recirculated to the vessel 1 via the fan 8.
- thermoelectric cooler is a solid heat pump in which the direct current flowing through the cooler provides heat transfer, forming a cooling side and a heating side.
- the thermoelectric cooler (s) 20 are placed in thermal conduction with the cooling surfaces 4a-4n in a manner that includes the use of thermally conductive grease or the like.
- the cooler 20 is arranged at a position where its cooling side cools the cooling surfaces 4a-4n.
- a modular design including a plurality of thermoelectric coolers 20 may be used.
- the heat sink 21 is also preferably arranged in a heat conducting relationship with the thermoelectric cooler (s) 20 to dissipate its heat. As shown, a fan 22 may be placed in the vicinity of the heat sink 21 to increase heat dissipation.
- thermoelectric cooler (s) 20 the amount of condensate produced by the condensing device 3 including the thermoelectric cooler (s) 20 is between 3 ° C and 60 ° C when the temperature of the cooling surfaces 4a-4n is between 3 ° C and 60 ° C. At one point, it was found that it was optimized efficiently. Appropriate Temperature ranges include 10-60 ° C and 30-55 ° C. At the bottom of the appropriate temperature range, multiple thermoelectric coolers are required, requiring larger heat sinks, larger fan airflows, and more power for the coolers and fans.
- the condensed liquid obtained by cooling the inside of the condenser 3 flows into the condensation chamber 30 located below the end face of the cooling surface 4a-4n at the lower end of the condenser 3. From the condensing chamber 30, the condensate flows into the drain pipe 31, from where it is sent to the extract storage tank and collected. All uncondensed vapors are recirculated to vessel 1 via pipe P 3 and fan 8 for further processing.
- At least one or more (two shown) air circulation or blowing means will be provided, preferably in the form of a fan or blower.
- the fan (s) 8 need to be large enough to provide the flow through the entire system due to the reduced pressure. Decompression should be within the range of about 5 ⁇ 5 0 O mm H 2 0. Conventional home vacuum cleaner fans have been found to be effective.
- Condenser 3 communicates with housing 1 via pipe P3.
- the valve V2 can be arranged in the pipe P3 to regulate the air flow and the pressure reduction together with the valve V1. For example, if valve V1 is partially closed while valve V2 is open, condenser 3 will be depressurized become. While valve V 1 is open, partially closing valve V 2 causes the pressure in condenser 3 to increase. Adjustment of the valve can be done manually or automatically.
- the raw material is ground to approximately the size of rice grains using appropriate means, and this is filled into the inner cylinder 2c shown in Fig. 5 (a). After filling, the raw material is covered with a net to keep it stable in the inner cylinder 2c.
- the housing 1 is filled with a sufficient amount of water or other liquid and can generate a mist.
- the water can be maintained at the same level continuously or can be added in batches.
- the temperature in the extraction device 2 is set to a level that does not destroy the active ingredients of the raw materials (generally 100 ° C). C or less).
- the water temperature is preferably heated to about 85 ° C and the water temperature when reaching the extractor is about 60 ° C.
- ⁇ 70 ° C preferably about 65 ° C.
- the blower (or blowers) 8 When the temperature in the housing 1 reaches the desired level, the blower (or blowers) 8 is activated to create a flow through the system.
- the blower (or blowers) 8 comprises a housing ⁇ , an extractor 2, a condenser 3 And an air flow is circulated in a closed circulation channel formed by pipes connecting these devices.
- the atomized water generated in the housing 1 thus passes through the pipe P together with the airflow and reaches the extraction device 2.
- the temperature inside the extraction device 2 can be measured by a temperature sensor to confirm that the inside has reached an appropriate temperature.
- the temperature inside the housing 1 can be controlled according to the temperature inside the extraction device 2.
- the air flow is circulated between each device by actuating the blower (s) 8, but since the extraction device 2 is filled with the crushed particles S of the raw material, This creates a reduced pressure space in the extraction device 2.
- the components in the raw material are extracted on the surface of the crushed pieces S of the raw material, and are then captured by the mist of water passing therethrough. Since the temperature in the extraction device, specifically, the temperature in the inner cylinder 2c is kept in a desired range, the components contained in the raw materials are extracted into water without being destroyed by heat.
- the resulting liquid (eg, water) contains the active ingredients of the raw materials and then flows with the airflow from the blower 8 to the condenser 3 via the connecting pipe P2.
- the outer cylinder 4 of the condenser 3 is filled with a coolant, preferably water, at a temperature sufficient to condense the water in the inner cylinder 5.
- Sky The air flow and the pressure reduction in the condenser 3 are controlled by adjusting the valves V 1 and V 2.
- the liquefied or condensed material is discharged through drain 7, as shown, and is finally collected via valve V3.
- the particles that are not liquefied in the condenser 3 are sucked together with the air flow via the connecting pipe P3 towards the housing 1 and are thereby recirculated.
- the recirculation part can be pre-heated using a flow straightening plate or spiral shape as needed, so that the water temperature in the tank 1 does not drop.
- the coolant in the condenser 3 may be changed periodically.
- the inner cylinder 5 may be cooled by a continuous flow of the cooling liquid.
- the raw materials may be ground to approximately rice grain size.
- the concentration of the active ingredient in the finished product can be controlled by changing the size of the raw materials. For example, by grinding raw materials into fine powder, a finished product with a high active ingredient concentration can be obtained. However, in such a case, the speed at which the finished product is manufactured decreases. As the size of the raw materials increases, the concentration of the active ingredient in the finished product decreases and the production speed increases. Similarly, the use of the guide plate 2d increases the finished product production per hour by about 20%, but decreases the active ingredient concentration in the finished product.
- circulating the humid air through the condenser to reduce or eliminate the humid air enables stable drying without being affected by outside air. Can be realized. As a result, the drying time and the associated energy requirements can be significantly reduced.
- the product is a clear, colorless liquid.
- the extract is then allowed to solidify.
- the procedure of the solidification treatment in the first embodiment is as follows.
- Appropriate materials include “Dyurapore” commercially available from Millipore Corporation Filament and other hydrophilic thin-film filters such as modified polyvinylidene fluoride membrane, glass fiber thin-film, cotton, nylon, cellulose, or paper materials used in tea bags Is included. Since there is no particular limitation on the shape of the material, the shape of the sheet and the disc may be included. The unique identity of the material selected for a given application will depend in part on the nature of the solvent used in subsequent steps, such as the analytical steps used to identify the active ingredient in the finished product.
- the absorbent material comes into contact with the extract.
- the absorbent material is preferably wetted over the entire area with the extract. If the absorbent material is a filter, use a driving force such as pressure or a vacuum (eg, using a vacuum pump) to push or pull the extract through the filter to completely wet the material with the extract.
- a driving force such as pressure or a vacuum (eg, using a vacuum pump) to push or pull the extract through the filter to completely wet the material with the extract.
- the absorbent material may optionally be heated before or during wetting with the extract to expand the pores and increase wetting. Alternatively or additionally, the extract may be heated alone or with the absorbent material.
- the extract is attached to the material, preferably by drying. Drying is performed by freeze drying, heating or air drying, and freeze drying is particularly preferred.
- the dried material can be stored for a considerable period of time without deterioration of the extract.
- This dried material can be dissolved in water or a suitable solvent, in which the active ingredients of the extract can also be dissolved. If desired, pressure may be increased to facilitate dissolution.
- the dried material may also be used for analysis, especially for drug research, or the solution obtained by first dissolving may be used for separation.
- the absorbent material used is paper
- the dried material can be dissolved in water and consumed as a health drink.
- freeze-drying step is evacuated in a temperature range of about 1 ° C. to about ⁇ 70 ° C. and a degree of vacuum of about 5.3 cfm to about 23 cfm.
- temperature and vacuum will vary depending on the nature and size of the material and the particular freeze dryer used.
- the amount of time to freeze-dry a substance can be easily determined by one skilled in the art, and to some extent depends on the concentration of the substance.
- the resulting product can be stored for an extended period of days or months without adversely affecting the quality or taste of the product.
- the resulting product tastes like water or other
- the active ingredients in the extract which can be destroyed by heating, are not lost by using the extraction process detailed above.
- the freeze-dried product also has a longer shelf life than the liquid extract and is compatible with chemical identification and chemical testing.
- the freeze-dried product can be easily reconstituted by adding a liquid carrier, preferably water, to the product.
- a liquid carrier preferably water
- the amount of liquid carrier added is not particularly limited and depends on the desired concentration of the extract in the final liquid.
- the freeze-dried product is intact (ie, without reverting to its original form) as an additive to other foods or other foods, such as salad garnish, dried soup ingredients, or admixed with other food ingredients Can be used with
- the freeze-dried product can be heated to disperse the vaporized aroma into the room.
- compositions containing an effective amount of the above compounds in a peptide are useful as human and animal drugs, particularly for the treatment and / or prevention of anti-inflammatory conditions.
- An effective amount for treating a patient is the amount of the composition that reduces or eliminates inflammation when administered to a patient in need thereof.
- Various inflammations for which the composition is effective include encephalitis, meningitis, blepharitis, conjunctivitis, keratitis, ulceris, retinitis, stomatitis, cheilitis, glossitis, tonsillitis, otitis media, otitis externa, Otitis media, gastritis, duodenitis, pneumonia, pleurisy, bronchitis, rhinitis, colitis, small intestinal inflammation, nephritis, pyeloneitis, prostatitis, cholecystitis, hepatitis, thyroiditis, prostatitis, cystitis, myotis, periosteitis, Osteomyelitis, orchitis, endometritis, vaginitis, ovitis, dermatitis, arthritis, perianalitis, Lymphoarthritis, diabetes (inflammation of the islands), cold (tonsillitis, bronchitis
- the therapeutic or prophylactic dosage of an extract of the present invention in the treatment or prevention of inflammation, when combined with a peptide, will depend, in part, on the nature, severity and nature of the condition to be treated. Dosage and frequency of dosing will also vary with the age, weight, and response of the particular patient. Generally, the total range of daily doses will be at least about 1 to 1 O mcg Z kg of body weight once a day, preferably 2 to 3 times a day. The dose for more severe symptoms should be at least once a day, about 10 to 100 mcg / kg of body weight. The frequency of dosing can be increased from about three to four times a day if needed or desired.
- compositions of the present invention can be combined with other therapeutic agents, such as analgesics.
- the pharmaceutical composition of the present invention is administered to animals including dogs, cats, fish and humans.
- Aqueous based carriers, auxiliary solvents such as ethyl alcohol, propylene glycol and dalyserin, fillers, lubricants, wetting agents, flavoring agents, coloring agents, emulsifying, suspending or dispersing agents, suspending agents, sweetening Pharmacologically acceptable carriers, including ingredients, and other conventional additives can be used.
- the extract solution is preferably prepared by simply mixing each of the four isolated compounds described above with an isolated peptide and orally administered without any carrier or additive.
- the ratio of each compound in the extraction composition is easily varied by mixing the appropriate amounts of each to formulate the final extraction solution. It is preferred to use equivalent amounts based on the weight of each compound.
- the peptide used in the present invention was isolated and identified as follows.
- the extraction method detailed above was used with coffee beans as raw material.
- the resulting extract was used to wet a glass fiber membrane (96.4 g).
- the membrane was extracted with 300 ml of each of the three ethyl acetates. Using a rotary evaporator, the ethyl acetate was brought to a nearly dry state under vacuum. The temperature of the solvent layer did not exceed 40 ° C. The residue was a light brown liquid (20.6 mI).
- the extract was extracted with 150 ml of ethyl ether, the ether layer was removed, and the extract was dried using anhydrous sodium sulfate.
- the extracted compound was characterized by its absorption spectrum and melting point, and was confirmed to be genistein, flavonic acid, daidzein and daidzin.
- Adjuvant-induced arthritis responds to both steroids and non-steroids. Determine the degree of inflammation by measuring the difference in foot weight and / or foot volume. Test organism
- Rats weighing 2 7 5 — 3 10 g were sent to Kani, Kenya Mar 'Technology purchased from one company. These were the talent of SD rats. Animals were individually housed in stainless steel cages with free access to water and food (Harlan Teclan rodent feed). The lighting cycle was bright for 12 hours and dark for 12 hours. The temperature was maintained at 22 ° C ⁇ 3 ° C and the relative humidity was between 40 and 70%.
- compositions were prepared by combining isolated compounds such as genistein, flavonic acid, daidzein, daidzin and a peptide having the amino acid sequence of tyrosine-glycine-serine-arginine-serine.
- isolated compounds such as genistein, flavonic acid, daidzein, daidzin and a peptide having the amino acid sequence of tyrosine-glycine-serine-arginine-serine.
- One milligram of each isolated compound was mixed in 9 ml of distilled water and 1 ml of alcohol. The mixture was then diluted to give a lOmcg dose per kilogram of body weight with daily tube feeding.
- the samples were given orally (tube feeding) once a day for 11 days.
- Sample is oral (tube feeding) per treatment group
- Each of the five rats was fed once a day for 11 days. Sample administration started on the day of inflammation.
- the left hind paw was measured just before sensitization and again on day 11. Compared with the non-sensitized rat group, the rate of inhibition of sole edema and the rate of weight gain were measured. The paw weight of each group was averaged. The anti-inflammatory activity was measured by comparing the paw weights by the following calculation method.
- composition 4 5 1 O m c g Z weight k 5 2 9 3 .3 3 7.4 4.1 g, composition 4 5
- adjuvant-induced arthritis could be suppressed by 100% by administering a composition containing five compounds isolated from coffee beans in an amount of 1 O mcg Z body weight kg.
- the composition achieved 69% inhibition.
- These values are higher than the 50% and 58% activities for hydrocortisone administered at 1 and 10 mcg / g body weight.
- animals treated with the composition gained weight to a level comparable to the control group, while animals treated with 1 O mcg Z weight kg of hydrocortisone gained weight. The rate of increase was reduced by about 50%.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/849,434 US20050261197A1 (en) | 2004-05-19 | 2004-05-19 | Coffee bean extract, method of extraction and composition containing the same |
US10/849,434 | 2004-05-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005110451A1 true WO2005110451A1 (ja) | 2005-11-24 |
Family
ID=35375945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/009306 WO2005110451A1 (ja) | 2004-05-19 | 2005-05-17 | コーヒー豆抽出物、抽出方法及び同抽出物を含む組成物 |
Country Status (2)
Country | Link |
---|---|
US (1) | US20050261197A1 (ja) |
WO (1) | WO2005110451A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003078448A1 (en) | 2002-03-13 | 2003-09-25 | Signum Biosciences, Inc. | Modulation of protein methylation and phosphoprotein phosphate |
WO2006084033A1 (en) | 2005-02-03 | 2006-08-10 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
TW201019948A (en) * | 2008-11-26 | 2010-06-01 | Han Sheng Pharmtech Inc | Local medication composition of coffee-bean extract and its application |
US20110009345A1 (en) * | 2009-07-08 | 2011-01-13 | Henry Aoki | Food ingredient comprising functional peptide |
US20110056823A1 (en) * | 2009-09-04 | 2011-03-10 | Henry Aoki | Methods and apparatus for extracting active ingredients |
US9592457B2 (en) * | 2014-02-11 | 2017-03-14 | Edwin Pajarillo DABAO | Oil extractor |
US10005816B2 (en) * | 2014-12-15 | 2018-06-26 | The Folger Coffee Company | Peptides and their use in food and beverage |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002506028A (ja) * | 1998-03-13 | 2002-02-26 | ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン | 糖尿病性網膜症または眼炎症の処置におけるゲニステインのようなタンパク質チロシンインヒビターの使用 |
JP2002530346A (ja) * | 1998-11-25 | 2002-09-17 | ニュートリ・ファーマ・アルメント・アクシェセルスカブ | 大豆蛋白質、食物繊維およびフィトエストロゲン化合物を含む組成物、および肺疾患の予防および/または治療におけるその使用 |
JP2002531493A (ja) * | 1998-12-11 | 2002-09-24 | ミシガン ステイト ユニヴァーシティー | サクランボバイオフラボノイドを使用するシクロオキシゲナーゼ及び炎症の抑制方法 |
JP2003026581A (ja) * | 2001-07-09 | 2003-01-29 | Ichimaru Pharcos Co Ltd | 化粧料組成物 |
JP2003117307A (ja) * | 2001-10-16 | 2003-04-22 | Kuboyama Kazuko | アロマの抽出方法とこれにより抽出されたアロマ。 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3652293A (en) * | 1969-01-09 | 1972-03-28 | Procter & Gamble | Instant coffee compositions exhibiting a crystalline sheen |
US4776104A (en) * | 1987-04-27 | 1988-10-11 | Kuboyama Nobuyoshi | Balanced extraction system |
US5170697A (en) * | 1991-11-12 | 1992-12-15 | Nobuyoshi Kuboyama | Extraction apparatus, process and product produced thereby |
US5572923A (en) * | 1995-06-26 | 1996-11-12 | Kuboyama; Nobuyoshi | Health beverage that an extracted ingredient from plant, animal or mineral is major ingredient, and manufacturing method and apparatus therefor |
US7390874B2 (en) * | 2003-12-29 | 2008-06-24 | Kuboyama Bio Ken, Inc. | Peptide, method of production thereof, and pharmaceutical composition containing the same |
-
2004
- 2004-05-19 US US10/849,434 patent/US20050261197A1/en not_active Abandoned
-
2005
- 2005-05-17 WO PCT/JP2005/009306 patent/WO2005110451A1/ja active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002506028A (ja) * | 1998-03-13 | 2002-02-26 | ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン | 糖尿病性網膜症または眼炎症の処置におけるゲニステインのようなタンパク質チロシンインヒビターの使用 |
JP2002530346A (ja) * | 1998-11-25 | 2002-09-17 | ニュートリ・ファーマ・アルメント・アクシェセルスカブ | 大豆蛋白質、食物繊維およびフィトエストロゲン化合物を含む組成物、および肺疾患の予防および/または治療におけるその使用 |
JP2002531493A (ja) * | 1998-12-11 | 2002-09-24 | ミシガン ステイト ユニヴァーシティー | サクランボバイオフラボノイドを使用するシクロオキシゲナーゼ及び炎症の抑制方法 |
JP2003026581A (ja) * | 2001-07-09 | 2003-01-29 | Ichimaru Pharcos Co Ltd | 化粧料組成物 |
JP2003117307A (ja) * | 2001-10-16 | 2003-04-22 | Kuboyama Kazuko | アロマの抽出方法とこれにより抽出されたアロマ。 |
Also Published As
Publication number | Publication date |
---|---|
US20050261197A1 (en) | 2005-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005110451A1 (ja) | コーヒー豆抽出物、抽出方法及び同抽出物を含む組成物 | |
JPH11207104A (ja) | 原材料より成分を抽出する装置 | |
US20020066663A1 (en) | Apparatus & method for enhanced solvent recovery from solvent extracted material | |
TW200537066A (en) | Heat treatment system using superheated steam | |
US20020178605A1 (en) | Method of reduction of aroma extract and resulting extract | |
EP1306020B1 (en) | Method of reduction of aroma extract and resulting extract | |
EP1710251B1 (en) | Novel peptide, process for producing the same and pharmaceutical composition containing the peptide | |
JP2848801B2 (ja) | 植物、動物または鉱物中から成分を抽出する方法及び装置並びに前記方法で抽出された成分を主成分とする健康飲料等及びその製造方法 | |
US6927234B2 (en) | Xanthone derivatives, method of production thereof, and pharmaceutical composition containing the same | |
JP2002226391A (ja) | 活性成分として原料の抽出物を含有する固体状組成物及びその製造方法 | |
CN1684655A (zh) | 利用桑那空间的人体有用物质的体内供给装置 | |
WO2014115067A1 (es) | Proceso para obtener proteinas concentradas de soja a partir del poroto mediante la extraccion con alcohol, obteniendose una harina de alta proteina sin factores antinutricionales y un aceite de alta calidad | |
US6001221A (en) | Extraction and drying apparatus | |
US20110009345A1 (en) | Food ingredient comprising functional peptide | |
CN114768299A (zh) | 蒲公英提取物的制备方法 | |
KR100660478B1 (ko) | 생약 추출물을 함유한 녹골 추출물의 제조방법과 이에 의해 제조된 녹골 추출물, 그리고 이를 함유하는 식품 | |
CN114052181B (zh) | 水稻gaba萌芽胚芽米及其生产工艺 | |
JP2003019475A (ja) | 食品残渣の乾燥方法及び乾燥装置 | |
CN105613868A (zh) | 一种具有舒肝和胃功效的玫瑰茉莉速溶茶的制备方法 | |
US20050287222A1 (en) | Method for producing water containing extracted ingredients from plant, animal, or mineral matter | |
CN113331267A (zh) | 一种花茶的制备方法 | |
JP2002355002A (ja) | 乾燥おから | |
GB2364931A (en) | Condensing apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |